<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pntd.0007747.t006" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pntd.0007747.t006</object-id>
 <label>Table 6</label>
 <caption>
  <title>Description of the sera origin used for the specific EDIII-IgG purification.</title>
 </caption>
 <alternatives>
  <graphic id="pntd.0007747.t006g" xlink:href="pntd.0007747.t006" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Groups purified on:</th>
     <th align="center" rowspan="1" colspan="1">ZEDIII (ZIKV pos.)</th>
     <th align="center" rowspan="1" colspan="1">D2EDIII (Flavivirus pos.)</th>
     <th align="center" rowspan="1" colspan="1">D4EDIII (Flavivirus pos.)</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">Number, n</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">20</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">20</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">20</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Gender, n women (%), n men (%), n ND (%)</td>
     <td align="center" rowspan="1" colspan="1">16 (80%), 4 (20%)</td>
     <td align="center" rowspan="1" colspan="1">12 (60%), 8 (40%)</td>
     <td align="center" rowspan="1" colspan="1">15 (75%), 5 (25%)</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">Age in years, median, IQR, (range), n ND (%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">33, 30–42, (21–70)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">50, 31–54, (6–75)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">52, 33–67, (17–73), 1 (5%)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">DPSO, median, IQR, (range), n ND (%)</td>
     <td align="center" rowspan="1" colspan="1">29, 19–66, (12–139), 2 (10%)</td>
     <td align="center" rowspan="1" colspan="1">45, 21–62, (8–90), 8 (40%)</td>
     <td align="center" rowspan="1" colspan="1">32, 9–75, (8–99), 9 (45%)</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">n ZIKV sero-neutralizer (%), n ND (%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">12 (60%), 8 (40%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">-</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">-</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">n Positive recognition of ZEDIII (%), (ODr range)</td>
     <td align="center" rowspan="1" colspan="1">20 (100%), (3.97–23.71)</td>
     <td align="center" rowspan="1" colspan="1">0 (0%), (0.30–1.49)</td>
     <td align="center" rowspan="1" colspan="1">0 (0%), (0.41–1.48)</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">n Positive recognition of D2EDIII (%), (ODr range)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">8 (40%), (0.72–6.27)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">20 (100%), (2.16–8.57)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">9 (45%), (0.60–13.11)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">n Positive recognition of D4EDIII (%), (ODr range)</td>
     <td align="center" rowspan="1" colspan="1">14 (70%), (0.81–8.92)</td>
     <td align="center" rowspan="1" colspan="1">10 (50%), (1.05–5.77)</td>
     <td align="center" rowspan="1" colspan="1">20 (100%), (3.10–23.56)</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">Sera origins</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1"/>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1"/>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">West Indies, n (%)</td>
     <td align="center" rowspan="1" colspan="1">1 (5%)</td>
     <td align="center" rowspan="1" colspan="1">-</td>
     <td align="center" rowspan="1" colspan="1">-</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">Guadeloupe, n (%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2 (10%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">9 (45%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">9 (45%)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Martinique, n (%)</td>
     <td align="center" rowspan="1" colspan="1">13 (65%)</td>
     <td align="center" rowspan="1" colspan="1">5 (25%)</td>
     <td align="center" rowspan="1" colspan="1">11 (55%)</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">New Caledonia, n (%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">1 (5%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">-</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">-</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Saint-Martin, n (%)</td>
     <td align="center" rowspan="1" colspan="1">2 (10%)</td>
     <td align="center" rowspan="1" colspan="1">6 (30%)</td>
     <td align="center" rowspan="1" colspan="1">-</td>
    </tr>
    <tr>
     <td align="left" style="background-color:#C0C0C0" rowspan="1" colspan="1">Venezuela, n (%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">1 (5%)</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">-</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">-</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t006fn001">
   <p>Abbreviations: ZEDIII, Zika virus envelope protein domain III; D2EDIII, Dengue virus serotype 2 envelope protein domain III; D4EDIII, Dengue virus serotype 4 envelope protein domain III; ND, not documented; DPSO, day post-symptoms onset; IQR, inter-quartile range; ODr, optical density ratio.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
